Natera, Inc. (NTRA)
NASDAQ: NTRA · Real-Time Price · USD
157.73
-0.32 (-0.20%)
At close: May 30, 2025, 4:00 PM
157.58
-0.15 (-0.10%)
After-hours: May 30, 2025, 7:48 PM EDT
Natera Employees
Natera had 4,434 employees as of December 31, 2024. The number of employees increased by 1,141 or 34.65% compared to the previous year.
Employees
4,434
Change (1Y)
1,141
Growth (1Y)
34.65%
Revenue / Employee
$412,945
Profits / Employee
-$42,797
Market Cap
21.54B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4,434 | 1,141 | 34.65% |
Dec 31, 2023 | 3,293 | 275 | 9.11% |
Dec 31, 2022 | 3,018 | 348 | 13.03% |
Dec 31, 2021 | 2,670 | 855 | 47.11% |
Dec 31, 2020 | 1,815 | 776 | 74.69% |
Dec 31, 2019 | 1,039 | 64 | 6.56% |
Dec 31, 2018 | 975 | 82 | 9.18% |
Dec 31, 2017 | 893 | 41 | 4.81% |
Dec 31, 2016 | 852 | 136 | 18.99% |
Dec 31, 2015 | 716 | 42 | 6.23% |
Dec 31, 2014 | 674 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
NTRA News
- 8 days ago - Natera to Present over 25 Signatera™ Studies at 2025 ASCO Annual Meeting - Business Wire
- 14 days ago - Natera: The Clues In Q1 Earnings - Seeking Alpha
- 22 days ago - Natera, Inc. (NTRA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Natera Reports First Quarter 2025 Financial Results - Business Wire
- 22 days ago - Signatera Data From I-SPY 2 Trial to Be Presented at ESMO Breast Annual Congress - Business Wire
- 23 days ago - Prospera™ Heart Test with DQS Outperforms dd-cfDNA Percentage in Detecting Allograft Rejection, New AJT Publication Shows - Business Wire
- 25 days ago - Largest Sarcoma Study to Date with ctDNA Analysis Demonstrates Excellent Performance for Signatera - Business Wire
- 4 weeks ago - Natera to Report its First Quarter Results on May 8, 2025 - Business Wire